Home › Asset managers › Compare 2025-2026 › Invesco vs ProShares
Invesco 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 27,103 | 24,538 | 2,251 | 314 | 91.6% | 91.2% |
| Board proposals | 24,863 | 22,533 | 2,126 | 204 | 91.4% | 91.1% |
| E&S shareholder proposals | 172 | 144 | 8 | 20 | 94.7% | 89.7% |
| Other items | 2,068 | 1,861 | 117 | 90 | 94.1% | 92.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,565 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Invesco | ProShares |
|---|---|---|---|---|---|---|
| QUALCOMM INCORPORATED | March 17, 2026 | Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting." Shareholder Rights and Defenses |
Other | Against | AGAINST 41 funds |
FOR 33 funds |
| RB GLOBAL INC | April 30, 2026 | Approval of a special resolution, requiring the Company to adopt a policy and amend its governing documents accordingly that all shareholder meetings will be held in a hybrid format with both in-person and virtual access as described in the accompanying proxy statement. Corporate Governance |
Other | Against | AGAINST 13 funds |
FOR 8 funds |
| REVVITY, INC. | April 28, 2026 | To approve the shareholder proposal regarding Executives to Retain Significant Stock. Compensation |
Other | Against | AGAINST 15 funds |
FOR 19 funds |
| ROOT, INC. | June 3, 2026 | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to allow for exculpation of certain officers. Director Elections |
Other | For | FOR 1 fund |
AGAINST 9 funds |
| SCILEX HOLDING COMPANY | December 11, 2025 | Proposal to approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve the Option Repricing Proposal. Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| SELLAS LIFE SCIENCES GROUP, INC. | June 16, 2026 | The approval of any postponement or adjournment of the 2026 Annual Meeting, from time to time, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the 2026 Annual Meeting to adopt the proposals set forth above or to establish a quorum. Corporate Governance |
Other | For | FOR 2 funds |
AGAINST 11 funds |
| SKILLSOFT CORP. | June 25, 2026 | To approve the adjournment of the Annual Meeting, to a later date or dates, if necessary or appropriate, as determined by the Board in its sole discretion, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve the presented proposals or to constitute a quorum. Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 9 funds |
| STRAWBERRY FIELDS REIT INC. | May 7, 2026 | To approve adjournment of the Annual Meeting, if necessary. Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 9 funds |
| Shanghai Baosight Software Co., Ltd. | October 10, 2025 | Amend Articles of Association Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| THE AES CORPORATION | April 29, 2026 | If properly presented, to vote on a non-binding stockholder proposal regarding stockholder ability to call a special meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 20 funds |
FOR 19 funds |
| THE GOLDMAN SACHS GROUP, INC. | April 29, 2026 | Shareholder Proposal Regarding Special Shareholder Meeting Thresholds Shareholder Rights and Defenses |
Other | Against | AGAINST 43 funds |
FOR 23 funds |
| THE SHERWIN-WILLIAMS COMPANY | April 22, 2026 | Shareholder Proposal Regarding Shareholder Ability to Call a Special Meeting Shareholder Rights and Defenses |
Other | Against | AGAINST 22 funds |
FOR 22 funds |
| THE TIMKEN COMPANY | May 8, 2026 | Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 8 funds |
FOR 7 funds |
| THE TRADE DESK, INC. | September 16, 2025 | The approval of one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve Proposal 1. Corporate Governance |
Other | For | FOR 23 funds |
AGAINST 26 funds |
| TILE SHOP HOLDINGS, INC. | December 3, 2025 | To grant discretionary authority to the holders of any proxy solicited by the Board of Directors, and each of them individually, to approve a motion to adjourn the special meeting to another time and place for the purpose of soliciting additional proxies in favor of proposal 1 or to obtain a quorum. Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 9 funds |
| Terex Corporation | January 28, 2026 | Proposal to approve the adjournment of the Terex special meeting to solicit additional proxies if there are not sufficient votes at the time of the Terex special meeting to approve the Terex stock issuance proposal (the "Terex adjournment proposal"). Corporate Governance |
Other | For | AGAINST 6 funds |
FOR 16 funds |
| VISA INC. | January 27, 2026 | Shareholder proposal on shareholder right to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 44 funds |
FOR 23 funds |
| VOYAGER TECHNOLOGIES, INC. | May 29, 2026 | To approve an adjournment of the Annual Meeting, if necessary, to solicit addition proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 3. Extraordinary Transactions |
Other | For | FOR 2 funds |
AGAINST 9 funds |
| WEATHERFORD INTERNATIONAL PLC | June 11, 2026 | To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediately and automatically acquired by Weatherford-US and/or its nominee(s) for the Scheme Consideration (as defined in the Scheme of Arrangement). Corporate Governance |
Other | For | FOR 10 funds |
AGAINST 10 funds |
| WEATHERFORD INTERNATIONAL PLC | June 11, 2026 | To approve any motion to adjourn the AGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the AGM to approve the resolutions proposed at the AGM. Corporate Governance |
Other | For | FOR 10 funds |
AGAINST 10 funds |
| WOLTERS KLUWER N.V. | May 21, 2026 | Amend Articles of Association Corporate Governance |
Other | For | FOR 4 funds |
AGAINST 2 funds |
| WYNDHAM HOTELS & RESORTS, INC. | May 14, 2026 | To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 7 funds |
FOR 9 funds |
| Zijin Mining Group Co., Ltd. | December 31, 2025 | Amend Administrative Measures for Connected Transactions Corporate Governance |
Other | For | FOR 4 funds |
AGAINST 1 fund |
| Zijin Mining Group Co., Ltd. | December 31, 2025 | Amend Articles of Association Corporate Governance |
Other | For | FOR 4 funds |
AGAINST 1 fund |
| Zijin Mining Group Co., Ltd. | December 31, 2025 | Amend Rules Governing the Procedures of Shareholders' Meetings Corporate Governance |
Other | For | FOR 4 funds |
AGAINST 1 fund |
| 1-800-FLOWERS.COM, INC. | December 10, 2025 | To approve an amendment to the 2003 Long Term Incentive and Share Award Plan to increase the authorized shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| 1-800-FLOWERS.COM, Inc. | December 10, 2025 | Election of Directors: Christina Shim Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 9 funds |
| 1-800-FLOWERS.COM, Inc. | December 10, 2025 | Election of Directors: Christopher G. McCann Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 9 funds |
| 1-800-FLOWERS.COM, Inc. | December 10, 2025 | Election of Directors: James F. McCann Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 9 funds |
| 1-800-FLOWERS.COM, Inc. | December 10, 2025 | Election of Directors: Larry Zarin Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 9 funds |
| 10X GENOMICS, INC. | June 4, 2026 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal Serge Saxonov Director Elections |
Board | For | FOR 4 funds |
AGAINST 10 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Directors for terms expiring April 2029: Timothy K. Ozark Director Elections |
Board | For | FOR 3 funds |
AGAINST 9 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Directors for terms expiring April 2029: Todd F. Schurz Director Elections |
Board | For | FOR 3 funds |
AGAINST 9 funds |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | FOR 1 fund |
AGAINST 10 funds |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers (''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| 8x8, Inc. | July 25, 2025 | To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 8 funds |
| A. O. Smith Corporation | April 13, 2026 | Election of directors: Christopher L. Mapes Director Elections |
Board | For | FOR 18 funds |
WITHHOLD 19 funds |
| AAR CORP. | September 16, 2025 | Election of four directors named in the proxy statement: Jeffrey N. Edwards Director Elections |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 3 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Andrew Kim Director Elections |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Charles Pappis Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 13 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: David H. Wang Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 13 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Tracy Liu Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 13 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| ACRES Commercial Realty Corp. | June 22, 2026 | Election of Directors: Murray S. Levin Director Elections |
Board | For | AGAINST 1 fund |
FOR 9 funds |
| ACV AUCTIONS INC. | May 27, 2026 | Elect the two Class II directors named in this Proxy Statement: Eileen Kamerick Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 9 funds |
| ACV Auctions Inc. | May 27, 2026 | Approve, on a non-binding, advisory basis, the compensation of our named executive officers; and Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| ADC Therapeutics SA | June 1, 2026 | Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers The Board of Directors proposes that the following proposal: "RESOLVED, that the Company's Shareholders approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in "Executive Compensation" and the related compensation tables and narrative disclosure in this proxy statement", be approved. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 14 funds |
| ADMA BIOLOGICS, INC. | June 2, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 20 funds |
FOR 15 funds |
| ADT INC. | May 27, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 6 funds |
| ADT Inc. | May 27, 2026 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 6 funds |
| ADVANCED DRAINAGE SYSTEMS, INC. | July 17, 2025 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 9 funds |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 14 funds |
AGAINST 16 funds |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | FOR 2 funds |
AGAINST 8 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve an amendment to the Company's 2023 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by an additional 2,500,000 shares of common stock Compensation |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| AENA SME SA | April 16, 2026 | REELECT MANUEL DELACAMPAGNE CRESPO AS DIRECTOR Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| AENA SME SA | April 16, 2026 | REELECT MAURICI LUCENA BETRIU AS DIRECTOR Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| AEROPORTS DE PARIS | May 21, 2026 | AUTHORIZE REPURCHASE OF UP TO 10 PERCENT OF ISSUED SHARE CAPITAL Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| AERSALE CORPORATION | June 11, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| AGILON HEALTH, INC. | June 2, 2026 | Approval, by advisory vote, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| AIRBNB INC | June 5, 2026 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan Blecharczyk. Director Elections |
Board | For | FOR 33 funds |
WITHHOLD 30 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 23 funds |
AGAINST 22 funds |
| AKEBIA THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| ALDEYRA THERAPEUTICS, INC. | June 9, 2026 | To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| ALECTOR, INC. | June 17, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ALKAMI TECHNOLOGY INC | May 19, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers, or NEOs. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ALLFUNDS GROUP PLC | May 7, 2026 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ALLIENT INC. | May 6, 2026 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 10 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| ALPHABET INC. | June 5, 2026 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock Compensation |
Board | For | FOR 62 funds |
AGAINST 35 funds |
| ALPHABET INC. | June 5, 2026 | Election of ten directors: Frances H. Arnold Director Elections |
Board | For | FOR 62 funds |
AGAINST 35 funds |
| ALPHABET INC. | June 5, 2026 | Election of ten directors: John L. Hennessy Director Elections |
Board | For | FOR 62 funds |
AGAINST 35 funds |
| ALPHATEC HOLDINGS, INC. | June 10, 2026 | To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan; Compensation |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 13 funds |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Carl E. Vogel Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Debra G. Perelman Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Matthew C. Blank Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| AMERESCO, INC. (AMRC) | June 4, 2026 | Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified. Claire Hughes-Johnson Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 9 funds |
| AMERICAN INTEGRITY INSURANCE GROUP, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers; and Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| AMKOR TECHNOLOGY, INC. | May 13, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 13 funds |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| ANGIODYNAMICS, INC. | November 10, 2025 | Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| ANNEXON, INC. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| ANYWHERE REAL ESTATE INC. | January 7, 2026 | To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Anywhere's named executive officers that is based on or otherwise relates to the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | ADVISORY VOTE TO APPROVE APOGEE'S EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 13 funds |
| APPIAN CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 10 funds |
| APTARGROUP, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 8 funds |
| AQUESTIVE THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| ARBOR REALTY TRUST, INC. | May 20, 2026 | Approval of an amendment and restatement to the Arbor Realty Trust, Inc. 2024 Amended Omnibus Stock Incentive Plan (the "Plan") to authorize an additional 8,000,000 shares of common stock of Arbor Realty Trust, Inc. for issuance under the Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 12 funds |
| ARBUTUS BIOPHARMA CORPORATION | May 26, 2026 | To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan; Compensation |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| ARBUTUS BIOPHARMA CORPORATION | May 26, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| ARCHER AVIATION INC. | June 26, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 16 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 12 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| ARES COMMERCIAL REAL ESTATE CORP | May 27, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2025, as described in the 2026 Proxy Statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
← Previous Page 2 of 26 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.